244 related articles for article (PubMed ID: 22044669)
1. The phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.
Nitsche C; Edderkaoui M; Moore RM; Eibl G; Kasahara N; Treger J; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
Gastroenterology; 2012 Feb; 142(2):377-87.e1-5. PubMed ID: 22044669
[TBL] [Abstract][Full Text] [Related]
2. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
[TBL] [Abstract][Full Text] [Related]
3. Depletion of Pleckstrin homology domain leucine-rich repeat protein phosphatases 1 and 2 by Bcr-Abl promotes chronic myelogenous leukemia cell proliferation through continuous phosphorylation of Akt isoforms.
Hirano I; Nakamura S; Yokota D; Ono T; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
J Biol Chem; 2009 Aug; 284(33):22155-22165. PubMed ID: 19261608
[TBL] [Abstract][Full Text] [Related]
4. PHLPP1 mediates melanoma metastasis suppression through repressing AKT2 activation.
Yu Y; Dai M; Lu A; Yu E; Merlino G
Oncogene; 2018 Apr; 37(17):2225-2236. PubMed ID: 29391600
[TBL] [Abstract][Full Text] [Related]
5. PHLPP isoforms differentially regulate Akt isoforms and AS160 affecting neuronal insulin signaling and insulin resistance via Scribble.
Sharma M; Dey CS
Cell Commun Signal; 2022 Nov; 20(1):179. PubMed ID: 36376971
[TBL] [Abstract][Full Text] [Related]
6. Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis.
Qiao M; Wang Y; Xu X; Lu J; Dong Y; Tao W; Stein J; Stein GS; Iglehart JD; Shi Q; Pardee AB
Mol Cell; 2010 May; 38(4):512-23. PubMed ID: 20513427
[TBL] [Abstract][Full Text] [Related]
7. Relationship between polycomb-group protein BMI-1 and phosphatases regulating AKT phosphorylation level in endometrial cancer.
Zaczek A; Jóźwiak P; Ciesielski P; Forma E; Wójcik-Krowiranda K; Cwonda Ł; Bieńkiewicz A; Bryś M; Krześlak A
J Cell Mol Med; 2020 Jan; 24(2):1300-1310. PubMed ID: 31863623
[TBL] [Abstract][Full Text] [Related]
8. PHLPPing through history: a decade in the life of PHLPP phosphatases.
Grzechnik AT; Newton AC
Biochem Soc Trans; 2016 Dec; 44(6):1675-1682. PubMed ID: 27913677
[TBL] [Abstract][Full Text] [Related]
9. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms.
Brognard J; Sierecki E; Gao T; Newton AC
Mol Cell; 2007 Mar; 25(6):917-31. PubMed ID: 17386267
[TBL] [Abstract][Full Text] [Related]
10. Tissue transglutaminase regulates focal adhesion kinase/AKT activation by modulating PTEN expression in pancreatic cancer cells.
Verma A; Guha S; Wang H; Fok JY; Koul D; Abbruzzese J; Mehta K
Clin Cancer Res; 2008 Apr; 14(7):1997-2005. PubMed ID: 18381937
[TBL] [Abstract][Full Text] [Related]
11. PHLPP negatively regulates cell motility through inhibition of Akt activity and integrin expression in pancreatic cancer cells.
Smith AJ; Wen YA; Stevens PD; Liu J; Wang C; Gao T
Oncotarget; 2016 Feb; 7(7):7801-15. PubMed ID: 26760962
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of PHLPP1 and PHLPP2 correlates with poor prognosis in patients with hypopharyngeal squamous cell carcinoma.
Zhou J; Yu X; Wang J; Li T; Jin T; Lei D; Pan X
PLoS One; 2015; 10(3):e0119405. PubMed ID: 25793736
[TBL] [Abstract][Full Text] [Related]
13. PHLPPs: Emerging players in metabolic disorders.
Balamurugan K; Chandra K; Sai Latha S; Swathi M; Joshi MB; Misra P; Parsa KVL
Drug Discov Today; 2022 Oct; 27(10):103317. PubMed ID: 35835313
[TBL] [Abstract][Full Text] [Related]
14. Clusterin enhances AKT2-mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit.
Bertacchini J; Mediani L; Beretti F; Guida M; Ghalali A; Brugnoli F; Bertagnolo V; Petricoin E; Poti F; Arioli J; Anselmi L; Bari A; McCubrey J; Martelli AM; Cocco L; Capitani S; Marmiroli S
J Cell Physiol; 2019 Jul; 234(7):11188-11199. PubMed ID: 30565691
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PHLPP1/2 phosphatases rescues pancreatic β-cells in diabetes.
Lupse B; Annamalai K; Ibrahim H; Kaur S; Geravandi S; Sarma B; Pal A; Awal S; Joshi A; Rafizadeh S; Madduri MK; Khazaei M; Liu H; Yuan T; He W; Gorrepati KDD; Azizi Z; Qi Q; Ye K; Oberholzer J; Maedler K; Ardestani A
Cell Rep; 2021 Aug; 36(5):109490. PubMed ID: 34348155
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes.
Jackson TC; Verrier JD; Drabek T; Janesko-Feldman K; Gillespie DG; Uray T; Dezfulian C; Clark RS; Bayir H; Jackson EK; Kochanek PM
J Pharmacol Exp Ther; 2013 Nov; 347(2):516-28. PubMed ID: 24023368
[TBL] [Abstract][Full Text] [Related]
17. Loss of PHLPP expression in colon cancer: role in proliferation and tumorigenesis.
Liu J; Weiss HL; Rychahou P; Jackson LN; Evers BM; Gao T
Oncogene; 2009 Feb; 28(7):994-1004. PubMed ID: 19079341
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 47 promotes tumor survival and therapy resistance by modulating AKT signaling
Chern Y; Zhang P; Ju H; Tai IT
Cancer Biol Med; 2020 May; 17(2):343-356. PubMed ID: 32587773
[No Abstract] [Full Text] [Related]
19. Cutting edge: PHLPP regulates the development, function, and molecular signaling pathways of regulatory T cells.
Patterson SJ; Han JM; Garcia R; Assi K; Gao T; O'Neill A; Newton AC; Levings MK
J Immunol; 2011 May; 186(10):5533-7. PubMed ID: 21498666
[TBL] [Abstract][Full Text] [Related]
20. Scribble-mediated membrane targeting of PHLPP1 is required for its negative regulation of Akt.
Li X; Yang H; Liu J; Schmidt MD; Gao T
EMBO Rep; 2011 Jun; 12(8):818-24. PubMed ID: 21701506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]